fbpx
01 / 05
Stuff of Progress, Pt. 10: Synthetic Pharmaceuticals

Blog Post | Health & Medical Care

Stuff of Progress, Pt. 10: Synthetic Pharmaceuticals

Synthetic Pharmaceuticals

In 1853, a French chemist named Charles Frédéric Gerhardt did something remarkable. He mastered an understanding of salicin, a naturally occurring chemical compound derived from the bark of willow trees – and went on to chemically synthesize salicylic acid, a synthetic form of natural salicin and civilization’s first synthetic pain reliever. In doing so, he helped to kick off the Pharmaceutical Revolution.

Humans had been unknowingly using the salicin found in many plants, but most especially willow bark, to treat pain since at least 1500 BCE, starting in Mesopotamia and Egypt. But knowing that a plant contains a useful treatment and understanding how to artificially synthesize that treatment from scratch are two very different things.

Mastering that technological jump in pharmaceutical chemistry took over three thousand years. Aside from pain relief, salicin had another great advantage. It could reduce inflammation, and break a fever, particularly in children.

Between 1897 and 1899, a German chemist named Felix Hoffmann, refined the process of synthesizing acetylsalicylic acid, a refined and improved form of the synthetic salicylic acid, while undertaking work for the Bayer Pharmaceutical Company based in Germany. The name that Bayer gave to the first mass produced pharmaceutical is as much a household name today as it was at the turn of the century. That name was Aspirin.

By 1950, Aspirin had become the most consumed painkiller globally. Today, we consume more than a hundred billion Aspirin tablets annually. Unlocking the chemistry and technology required to produce acetylsalicylic acid was the key to developing the first in a series of tens of thousands of natural and synthetic pharmaceutical compounds produced between the height of the Industrial Revolution and today.

It is all too easy to forget how greatly modern pharmaceuticals have transformed our collective lives. From insulin to modern contraceptive tablets and from acetaminophen to paracetamol, these compounds run the spectrum from life enriching to literally life-saving.

The U.S. Food and Drug Administration (FDA) alone regulates an estimated 20,000 prescription drugs and chemical compounds used to treat thousands of conditions. The pharmaceutical compounds we have at our disposal have helped to dramatically reduce the burden of disease in both the developed and developing world.

Scientific progress,  stimulated by expanding and largely free globalized trade network, helped to advance both the development and utilization of key pharmaceutical breakthroughs. It is no exaggeration to say that some of the more prominent pharmaceutical drugs significantly impacted life expectancy averages, as well as our general wellbeing.

Starting at the dawn of the Industrial Revolution, civilization began to turn out a series of groundbreaking pharmaceutical drugs, antibiotics, vaccines and much more. Some of those key drugs included Ether and Morphine, powerful pain blockers, invented in 1842 and 1827 respectively. Insulin, an effective diabetes treatment, was developed in 1922; penicillin, a powerful antibiotic, in 1942; drug treatments for tuberculosis in 1951; oral contraceptives in the 1960s; salbutamol to treat asthma in 1966; and a series of effective chemotherapy drugs and HIV inhibitors in the 1990s.

Humanity has accomplished all that and more. Powerful modern anesthetics, antibiotics, antimalarials or vaccines which have also saved hundreds of millions of lives – especially those of children.

Today the global pharmaceutical market is worth more than 1.1 trillion U.S. dollars, having grown by more than 5 percent over the previous year alone.The same market forces, which have helped to provide inexpensive and abundant energy, and fast and reliable communications and travel, have also helped to drive forward an industry that has improved the health and wellbeing of billions.

Today, most people living in developed countries have relatively inexpensive access to a vast spectrum of affordable over the counter and prescription medications, the likes of which couldn’t have been dreamed of by even the most optimistic medical chemists of the late 1800s.

For less than the price of a coffee, you can rid yourself of a headache, take a dose of antibiotic to treat an infection, break a child’s fever, provide a dose of oral rehydration therapy or allergy antihistamine. The good news is that innovation and progress within the pharmaceutical industry continues to drive human progress.

That is all the more important as the world’s scientists race to develop inexpensive, effective and swiftly deployable treatments and vaccines to combat the SARS-COV-2 coronavirus pandemic.

The Guardian | Drug Use

Weight Loss Drugs May Prevent Addiction to Drugs and Alcohol

“Weight loss drugs could help people avoid getting addicted to alcohol, tobacco and drugs such as cannabis and cocaine, a study has found.

They could also reduce the risk of people already addicted to illicit substances having an overdose, ending up in hospital or dying, according to research published in the British Medical Journal.

Glucagon-like peptide-1 receptor agonists used to treat type 2 diabetes and obesity, such as Mounjaro and Ozempic, are thought to work by influencing the brain’s reward pathways in order to cut cravings. They help people feel fuller by mimicking the natural substance released after eating.

The US study analysed 606,434 US veterans with type 2 diabetes, who were monitored for up to three years. It found that GLP-1s reduced the risk of alcohol-related disorders in those with no history of substance use by 18% and of using cannabis (14%), cocaine (20%), nicotine (20%) and opioids (25%), compared with those on other sodium-glucose cotransporter-2 drugs also used to treat diabetes.

Weight loss drugs also reduce the risk of people already using substances from overdosing (39%), needing emergency help in A&E (31%) or dying (50%).”

From The Guardian.

Wall Street Journal | Life Expectancy

Drop in Drug Overdoses Boosts US Life Expectancy to All-Time High

“Life expectancy in the U.S. reached a record high in 2024 following a substantial decline of drug-overdose deaths, according to figures released by the federal government Thursday.

The life expectancy at birth for the average American was 79 years old in 2024, up 0.6 year from the year prior, according to a report from the Centers for Disease Control and Prevention’s National Center for Health Statistics. The increase signals a rebound from declines in life expectancy during the coronavirus pandemic and progress in combating the opioid crisis.

The agency reported that deaths related to drug overdose decreased by more than 26% between 2023 and 2024, marking the largest year-to-year drop in those types of fatalities recorded by the federal government.”

From Wall Street Journal.

Los Angeles Times | Drug Use

US Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

“U.S. overdose deaths fell through most of last year, suggesting a lasting improvement in an epidemic that had been worsening for decades.

Federal data released Wednesday showed that overdose deaths have been falling for more than two years — the longest drop in decades — but also that the decline was slowing.

Deaths began steadily climbing in the 1990s with overdoses involving opioid painkillers, followed by waves of deaths from heroin and — more recently — illicit fentanyl. Deaths peaked at nearly 110,000 in 2022, fell a little in 2023 and then plummeted 27% in 2024, to around 80,000. That was the largest one-year decline ever recorded…

The new Centers for Disease Control and Prevention data run through August 2025 and represents the first update of monthly provisional drug overdose deaths since the federal government shutdown.

An estimated 73,000 people died from overdoses in the 12-month period that ended August 2025, down about 21% from the 92,000 in the previous 12-month period.

CDC officials reported that deaths were down in all states except Arizona, Hawaii, Kansas, New Mexico and North Dakota. But they noted it’s likely that not all overdose deaths have been reported yet in every state, and additional data in the future might affect that state count.”

From Los Angeles Times.

NPR | Drug Use

Drug Deaths Plummet Among Young Americans as Fentanyl Carnage Eases

“‘What we’re seeing is a massive reduction in [fatal] overdose risk, among Gen Z in particular,’ said Nabarun Dasgupta, an addiction researcher at the University of North Carolina. ‘Ages 20 to 29 lowered the risk by 47%, cut it right in half.’

This stunning drop in drug deaths among people in the U.S. is being tracked in data compiled by the Centers for Disease Control and Prevention and other federal agencies.

The latest available records found fentanyl and other drugs killed more than 31,000 people (see chart) under the age of 35 in 2021. By last year, that number had plummeted to roughly 16,690 fatal overdoses, according to provisional CDC data.”

From NPR.